Hims & Hers Health remote pharmacy reports Q4 revenue of $617 million, analysts expected $619.3 million

Fourth quarter earnings per share (EPS) were $0.08, compared to $0.11 in the same period last year. Fourth quarter operating expenses were $435.2 million, while analysts expected $454.7 million. Total number of subscription users in the fourth quarter was 2.51 million, with analysts expecting 2.57 million. Revenue for 2026 is expected to be between $2.7 billion and $2.9 billion, with analysts expecting $2.75 billion. First quarter revenue is expected to be between $600 million and $625 million, while analysts expected $653.9 million.